Invest in

Fighting Fat

3.3%
1.8%
0.0%

Losing Weight – By Any Means Necessary

More than one-third of the US population is now officially obese (a body-mass index over 30) – a ratio that has tripled since 1960.[1] Meanwhile, the number of morbidly obese people has risen 350% in the past 3 decades.[5] Obesity contributes to many of the country’s serious health issues, from coronary disease, to diabetes to cancer, which results in close to 112,000 preventable deaths[2] while eating up 21% of US medical spending each year.[3] As big as US citizens are getting, the roster of companies joining the fight against obesity is also growing, with one weight-loss drug, Qysmia, expected to reach $2 billion in annual sales by 2017.[4] Whether companies are selling pharmaceuticals, surgeries or diet plans, fighting fat is literally big business. See more
3.3%
1.8%
0.0%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for just $9.95.
Motif Index 1 YR Return
Fighting Fat Benchmark
With this Motif, you can buy the following basket of stocks for just $9.95:
Weight Segment & Stocks Symbol 1 MO / 1 YR Return
55.6% Diabetes Care 2.1%
17.7% Merck & Company Inc. (new) MRK 20.8%
17.1% Novo Nordisk A/S NVO 12.8%
14.3% Sanofi American Depositary Shares (Each repstg one-half of one) SNY 17.3%
3.2% Astrazeneca Plc ADR AZN 10.5%
1.9% Alkermes plc ALKS 25.3%
1.4% Integer Holdings Corporation ITGR --
37.5% Weight Management 17.1%
15.4% NutriSystem Inc NTRI 5.9%
8.2% MEDIFAST INC MED 34.5%
4.1% Nu Skin Enterprises Inc. (A) NUS 32.8%
3.9% Weight Watchers International Inc WTW 74.8%
2.4% USANA Health Sciences Inc. USNA 6.9%
1.8% Vitamin Shoppe Inc VSI 24.9%
1.7% GNC Holdings Inc. Class A GNC 57.0%
6.9% Weight Loss Drugs 39.9%
6.9% Arena Pharmaceuticals Inc. ARNA 39.9%

Quotes delayed 15 mins. Currently Aug 31, 2016 12:17:33 AM. Fields are marked with -- when data is unavailable.